Tseng, Tzu-Ning

Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mL. [electronic resource] - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 11 2020 - 2803-2812.e2 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1542-7714

10.1016/j.cgh.2020.04.037 doi


Antigens, Surface--therapeutic use
Antiviral Agents--therapeutic use
DNA, Viral
Guanine--analogs & derivatives
Hepatitis B Surface Antigens
Hepatitis B virus--genetics
Hepatitis B, Chronic--drug therapy
Humans
Incidence
Recurrence
Tenofovir--therapeutic use
Treatment Outcome